Mylan CEO sees astronomical pay raise from EpiPen sales

‘Countdown to the Closing Bell’ Host Liz Claman, Forbes contributor Carrie Sheffield and Kingsview Asset Management’s Chief Investment Officer Scott Martin discuss the Mylan CEO receiving a 671% raise while the price of EpiPen continues to rise.

Advertisement